Calendar IN8bio, Inc.

Equities

INAB

US45674E1091

Real-time Estimate Cboe BZX 12:17:27 2024-06-03 pm EDT 5-day change 1st Jan Change
1.07 USD -10.08% Intraday chart for IN8bio, Inc. -0.72% -24.46%

Chart calendar IN8bio, Inc.

a56b785bb7032dec47.0XBzOQUKDPLxdOESlnFc2bla8OjOkTzGfJsnfNm1PXI.nUkRZmg9Y625JYtnxAMSqtYyobCi6UnrCMRNSZvQdiOHCjYUMT09xok_sA~991bf94510657dcc7e834fde6e99042b

Upcoming events on IN8bio, Inc.

2024-06-12 09:00 am Annual General Meeting
2024-06-14 04:00 am European Hematology Association Meeting - Poster Session: P1460
2024-08-08 Q2 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)
2026-05-06 Q1 2026 Earnings Release (Projected)

Past events on IN8bio, Inc.

2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : 2042
2024-05-10 03:45 pm American Society of Gene & Cell Therapy Meeting - Abstract Number: 282
2024-05-09 04:00 pm Q1 2024 Earnings Release
2024-04-18 12:30 pm Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract Number: 5227
2024-03-26 03:00 pm H.C. Wainwright Cell Therapy Virtual Conference
2024-03-19 Benzinga Virtual Healthcare Summit
2024-03-14 04:00 pm Q4 2023 Earnings Release
2024-03-04 09:50 am TD Cowen Health Care Conference
2023-12-12 08:30 am American Society of Hematology Meeting
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract #: 4853
2023-12-08 American Society of Hematology Meeting
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Abstract No CTIM 35
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Abstract Number: CTIM-42
2023-11-07 Truist Securities Healthcare Conference
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract #: 418
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract #: 637
2023-10-12 09:00 am R&D Day
2023-09-27 08:35 am Cantor Global Healthcare Conference
2023-09-13 02:00 pm H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-14,7
-12,4
-18.17%
-28,5
-27,9
-2.34%
-30,3
-29,5
-2.73%

-33,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
-29,7
-

-37,0

Net income
Million USD
Released
Forecast
Spread
-8,56


0,00
0,00
-
0,00
0,00
-
0,00
-29,7
-

-37,0

EPS
USD
Released
Forecast
Spread
-3,02


0,00
0,00
-
0,00
0,00
-
0,00
-0,93
-

-0,71

Announcement Date31/03/2117/03/2230/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-6,15
-3,57
-72.13%
-7,18
-4,75
-51.14%
-7,40
-6,71
-10.27%
-7,80
-7,15
-8.99%
-7,53
-7,79
3.34%
-7,72
-7,82
1.38%
-7,17
-7,35
2.46%
-7,93
-6,77
-17.08%
-8,56
-7,58
-13%

-8,01


-8,18


-8,51







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






















-7,30

-8,56
-7,31
-17.21%

-8,95


-9,49


-9,98







Net income
Million USD
Released
Forecast
Spread






















-7,30

-8,56
-7,31
-17.21%

-8,95


-9,49


-9,98







EPS
USD
Released
Forecast
Spread






















-0,17

-0,20
-0,18
-14.29%

-0,19


-0,19


-0,16







Announcement Date12/05/2212/08/2210/11/2230/03/2312/05/2310/08/2309/11/2314/03/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise